Thirty Madison launched a new telehealth brand for people with seasonal allergies. It’s the latest addition to the company’s growing list of direct-to-consumer brands, which include hair loss, migraines and acid reflux.
On Episode 143 of Health in 2 Point 00, we have all the alphabets in the raising series represented ;)! Jess asks me about Lumeon raising a $30M Series D for their care orchestration centers, Nurx raising a $22M Series C to develop out its… Read More »Health in 2 Point 00, Episode 143 | Lumeon, Nurx, Thirty Madison, & More
Thirty Madison, which owns direct-to-consumer pharmacy brands for hair loss, migraines and acid reflux, raised $47 million in a series B round. Polaris Partners led the round, and Johnson & Johnson participated as an investor.